Achieve Life Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Achieve Life Sciences, Inc. (ACHV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 428.07 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-11
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 358.48K shares.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 69.60K shares.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 13.65K shares.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 16.50K shares.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 1.41K shares, a 299.43% increase from fiscal 2019.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 352.00 shares, a 10.43% decline from fiscal 2018.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 393.00 shares, a 98.71% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 358.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 428.07K shares 10-Q · filed 2026-08-11 | 428.07K shares derived: sum of 3 quarters · filed 2026-08-11 | 441.73K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 69.60K shares 10-Q · filed 2026-05-12 | 69.60K shares derived: sum of 2 quarters · filed 2026-05-12 | 83.25K shares derived: sum of 3 quarters · filed 2026-05-12 | |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 13.65K shares derived: sum of 2 quarters · filed 2026-03-24 | 16.50K shares 10-K · filed 2026-03-24 | |
| 2025-09-30 | 13.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 16.50K shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 2.85K shares 10-Q · filed 2025-08-07 | |||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -3.00 shares derived: sum of 2 quarters · filed 2021-03-11 | -17.35K shares derived: sum of 3 quarters · filed 2021-03-11 | 1.41K shares 10-K · filed 2021-03-11 |
| 2020-09-30 | -3.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -17.35K shares derived: sum of 2 quarters · filed 2020-11-12 | 1.41K shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -17.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 1.41K shares 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | 18.76K shares 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | 352.00 shares 10-K · filed 2020-03-13 | |||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-14 | -2.85K shares derived: sum of 3 quarters · filed 2019-03-14 | 393.00 shares 10-K · filed 2019-03-14 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -2.85K shares derived: sum of 2 quarters · filed 2018-11-07 | 393.00 shares 10-Q · filed 2018-11-07 | |
| 2018-06-30 | -2.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 393.00 shares 10-Q · filed 2018-08-08 | ||
| 2018-03-31 | 3.24K shares 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | 30.46K shares 10-K · filed 2018-03-01 | |||
| 2017-06-30 | -12.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | 17.68K shares 10-Q · filed 2017-07-31 | 635.29K shares derived: sum of 3 quarters · filed 2017-07-31 | 665.52K shares derived: sum of 4 quarters · filed 2017-07-31 |
| 2017-03-31 | 30.17K shares 10-Q · filed 2017-05-15 | 647.78K shares derived: sum of 2 quarters · filed 2017-05-15 | 678.02K shares derived: sum of 3 quarters · filed 2017-05-15 | 739.58K shares derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-12-31 | 617.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 647.84K shares derived: sum of 2 quarters · filed 2017-02-23 | 709.40K shares derived: sum of 3 quarters · filed 2017-02-23 | 741.61K shares 10-K · filed 2017-02-23 |
| 2016-09-30 | 30.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 91.79K shares derived: sum of 2 quarters · filed 2016-11-10 | 124.00K shares 10-Q · filed 2016-11-10 | 124.00K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2016-06-30 | 61.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 93.76K shares 10-Q · filed 2016-08-04 | 93.76K shares derived: sum of 3 quarters · filed 2017-02-23 | 129.51K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2016-03-31 | 32.20K shares 10-Q · filed 2016-05-12 | 32.20K shares derived: sum of 2 quarters · filed 2017-02-23 | 67.95K shares derived: sum of 3 quarters · filed 2017-02-23 | 72.72K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 35.75K shares derived: sum of 2 quarters · filed 2017-02-23 | 40.52K shares derived: sum of 3 quarters · filed 2017-02-23 | 53.12K shares 10-K · filed 2017-02-23 |
| 2015-09-30 | 35.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 40.52K shares derived: sum of 2 quarters · filed 2015-11-12 | 53.12K shares 10-Q · filed 2015-11-12 | 81.56K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | 4.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 17.37K shares 10-Q · filed 2015-08-13 | 45.81K shares derived: sum of 3 quarters · filed 2017-02-23 | 89.94K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | 12.60K shares 10-Q · filed 2015-05-14 | 41.05K shares derived: sum of 2 quarters · filed 2017-02-23 | 85.17K shares derived: sum of 3 quarters · filed 2017-02-23 | |
| 2014-12-31 | 28.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 72.56K shares derived: sum of 2 quarters · filed 2017-02-23 | 84.00K shares 10-K · filed 2017-02-23 | |
| 2014-09-30 | 44.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | 55.56K shares 10-Q · filed 2014-10-30 | ||
| 2014-06-30 | 11.44K shares 10-Q · filed 2014-08-07 | |||
| 2013-12-31 | 8.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | 23.24K shares derived: sum of 2 quarters · filed 2016-03-09 | 30.34K shares derived: sum of 3 quarters · filed 2016-03-09 | 30.54K shares 10-K · filed 2016-03-09 |
| 2013-09-30 | 14.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 21.71K shares derived: sum of 2 quarters · filed 2013-11-07 | 21.91K shares 10-Q · filed 2013-11-07 | 30.99K shares derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-06-30 | 7.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 7.30K shares 10-Q · filed 2013-08-08 | 16.38K shares derived: sum of 3 quarters · filed 2015-03-26 | 16.38K shares derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-03-31 | 200.00 shares 10-Q · filed 2013-05-02 | 9.28K shares derived: sum of 2 quarters · filed 2015-03-26 | 9.28K shares derived: sum of 3 quarters · filed 2015-03-26 | |
| 2012-12-31 | 9.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | 9.08K shares derived: sum of 2 quarters · filed 2015-03-26 | 4.54K shares 10-K · filed 2015-03-26 | |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -4.54K shares 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | -4.54K shares 10-Q · filed 2012-08-02 | |||
| 2011-12-31 | 971.00 shares 10-K · filed 2014-03-11 | |||
| 2010-12-31 | 26.56K shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |